Fmoc-N-Me-Phe-OH is a peptide inhibitor of Malaria Parasite.
CAT No: R1361
CAS No:77128-73-5
Synonyms/Alias:Fmoc-N-Me-Phe-OH;77128-73-5;Fmoc-MePhe-OH;Fmoc-N-methyl-L-phenylalanine;(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)(methyl)amino)-3-phenylpropanoic acid;N-Fmoc-N-methyl-L-phenylalanine;Fmoc-N-Me-L-Phe-OH;(2S)-2-[9H-fluoren-9-ylmethoxycarbonyl(methyl)amino]-3-phenylpropanoic acid;MFCD00151938;N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-N-methyl-L-phenylalanine;Fmoc-L-MePhe-OH;N-alpha-(9-Fluorenylmethyloxycarbonyl)-N-alpha-methyl-L-phenylalanine;(S)-2-[[[(9H-Fluoren-9-yl)methoxy]carbonyl](methyl)amino]-3-phenylpropanoic acid;Fmoc-Nalpha-methyl-L-phenylalanine;L-Phenylalanine, N-[(9H-fluoren-9-ylmethoxy)carbonyl]-N-methyl-;(2S)-2-{[(9H-fluoren-9-ylmethoxy)carbonyl](methyl)amino}-3-phenylpropanoic acid;SCHEMBL120595;GBROUWPNYVBLFO-QHCPKHFHSA-N;ZB0880;AKOS015837150;AKOS015908459;CS-W011702;HY-W010986;AC-24162;DA-63560;DS-13395;F1167;EN300-1692653;Fmoc-N-Me-Phe-OH, >=99.0% (sum of enantiomers, HPLC);N-(((9H-Fluoren-9-yl)methoxy)carbonyl)-N-methyl-L-phenylalanine;(2S)-2-({[(9H-fluoren-9-yl)methoxy]carbonyl}(methyl)amino)-3-phenylpropanoic acid;(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)(methyl)amino)-3-phenylpropanoicacid;844-850-8;
Fmoc-N-Me-Phe-OH, also known as N-α-Fmoc-N-methyl-L-phenylalanine, is a specialty amino acid derivative widely utilized in peptide chemistry and research. Structurally, it features the N-terminal 9-fluorenylmethoxycarbonyl (Fmoc) protecting group and a methylation on the amide nitrogen of the phenylalanine residue. This unique configuration imparts both steric and electronic modifications, making it a crucial building block for the synthesis of peptides with enhanced conformational properties and resistance to enzymatic degradation. Its role in facilitating the generation of structurally diverse and functionally optimized peptides underpins its significance within the fields of medicinal chemistry, structural biology, and chemical biology.
Peptide Synthesis: As a protected N-methyl amino acid, Fmoc-N-Me-Phe-OH is indispensable in solid-phase peptide synthesis (SPPS) protocols, particularly for the assembly of peptides containing N-methylated residues. Incorporation of N-methylphenylalanine units can modulate backbone flexibility and disrupt regular hydrogen bonding patterns, enabling the design of peptides with altered secondary structures. This property is especially valuable for researchers aiming to synthesize conformationally constrained peptides or to introduce non-natural modifications that enhance peptide stability and bioactivity.
Peptidomimetic Development: The N-methylation of the amide nitrogen in this derivative is a strategic modification frequently employed in the creation of peptidomimetics—molecules that mimic the structure and function of natural peptides but with improved pharmacokinetic attributes. By integrating Fmoc-N-Me-Phe-OH into peptide sequences, scientists can systematically investigate the impact of backbone methylation on target binding affinity, protease resistance, and cellular permeability. These studies are fundamental for the development of next-generation peptide-based research tools and bioactive compounds.
Structure-Activity Relationship Studies: The introduction of N-methylated phenylalanine residues via this reagent allows for detailed structure-activity relationship (SAR) analyses in peptide research. By selectively modifying the peptide backbone, researchers can probe the influence of steric bulk and hydrogen bond disruption on receptor interactions, ligand specificity, and functional outcomes. Such SAR studies are instrumental in elucidating the molecular determinants of peptide recognition and activity, providing insights that guide the rational design of optimized analogues.
Protease Resistance Evaluation: N-methylated amino acids like Fmoc-N-Me-Phe-OH are routinely used to engineer peptides with enhanced resistance to proteolytic degradation. The methyl group on the amide nitrogen hinders protease access and cleavage, thereby extending peptide half-life in biological assays and experimental systems. This property is particularly advantageous for researchers seeking to evaluate the stability and persistence of novel peptide sequences in vitro, facilitating the development of robust research reagents and model compounds.
Conformational Analysis: The incorporation of N-methylphenylalanine into peptides serves as a powerful tool for investigating backbone conformational preferences and folding dynamics. By constraining the peptide backbone, this derivative enables the study of non-canonical secondary structures, such as β-turns and helical motifs, and aids in the elucidation of structure-function relationships in synthetic and natural peptides. Such conformational analyses are critical in advancing our understanding of peptide folding, molecular recognition, and the design of bioactive scaffolds for research applications.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.